Elisabetta
Abruzzese and Giuseppe Leone for the Editorial Board of the
Mediterranean Journal of Hematology and Infectious Diseases..
Published: January 1, 2022
Received: December 20, 2021
Accepted: December 22, 2021
This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0),
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
|
Dear Collegues,
With
great sorrow, we inform the readers of the MJHID of the death of
Professor Michele Baccarani underwent on December 20, 2021.
His
scientific contributions were fundamental to the advancement of
hematology, and his intuition and vision of the future changed the
history of chronic myeloid leukemia. Prof. Baccarani was the first to
describe the goals for the treatment of LMC and the responses of LMC
patients to targeted treatments. He was a distinguished member of both
ASH, ELN, and, of course, Italian scientific societies. Prof. Baccarani
was a legend in our field, a brilliant investigator, a dedicated
physician and a dear mentor; his guidance, intelligence,
thoughtfulness, and insight will be sorely missed. We are particularly
grateful to Prof. Baccarani for having been the Guest Editor of the
Review Series on Chronic Myeloid Leukemia, published on the MJHD in
August 2014.
[TOP]
